Bellway reports full-year results on 13 October. We preview reservation trends, margin pressure, the impact of the new first-time-buyer scheme and what to watch on the day.

Spot gold's August-to-October decline remains in play even though the 2024-to-2026 uptrend line at $4,124.75 per troy ounce holds for now. As long as it and last week's low at $4,110.87 hold, further ...

Technical analysis of the S&P 500 as it bounces off its 2026 uptrend line while EUR/GBP slides and the silver price range trades above minor support.

Nike reports fiscal Q1 2027 earnings on 1 October. We preview China performance, gross margin trends, wholesale versus Direct and the outlook for the turnaround.

Brent crude climbed above $107 a barrel for a second consecutive session as concerns over Middle East supply disruptions linked to the US-Iran war outweighed signs of recovering Gulf exports. Dollar ...

Micron reports fiscal Q4 earnings on 30 September with revenue guidance of $50bn. We preview HBM demand, gross margin trends, FY2027 guidance and what to watch.

If you’ve lost or forgotten your login details, click on ‘forgotten your login details’, as shown below. Then, enter your registered email address to retrieve your login details. Your login details ...

AstraZeneca shares hit a two-month high after a $2bn Summit Therapeutics deal. We look at what ivonescimab means for AstraZeneca's oncology pipeline and the shares.

US 10-year yields hit 5.34% while UK 30-year gilts breached 6%. We explain why rapidly rising bond yields tighten financial conditions and what it means for investors.

Palantir shares are near $187.50 as US commercial revenue surged 149% in Q2. We look at the AI growth story, the valuation debate and what comes next for the shares.

Technical analysis of the DAX 40 as it falls through key support while AUD/USD, copper price remain under pressure.

Anthropic targets a valuation above $2 trillion in its IPO. Explore its revenue, losses, AI risks and how IG’s pre-IPO market works.